CentreC3i

C3i is a one-stop shop in the development chain of cell & gene therapy.

We are partner-focused and patient-driven.

We are a CDMO offering cost-effective CGT manufacturing from process development to phase III for the US, EU, and Canada with commercial manufacturing in 2024. All without needing tech transfer to multiple sites.

Our advantages are:

• High production success rate of ~99%

• Attractive COGS (>25% cheaper than other US/EU CDMOs)

• C3i offers analytical testing including validated Qc tests

• CAP-accredited immune-monitoring and diagnostic testing services

• CRO services specializing in cell therapy clinical trials

• Partnership with a leading research hospital and access to KOLs

• Offers a unique shared risk model by investing in innovative companies and offering in-kind services.

Our vision is to make life-saving cell & gene therapies available to everyone who needs it. Our team truly understands that we are not just working with the patient’s cells but with a loved one’s chance at life.

C3i’s mission is to develop and manufacture cost-effective state-of-the-art integrated cell and gene therapies making it accessible to people in need.

Our values are Excellence, Responsiveness, Collaboration, Integrity, and Empathy. They define who we are and how we pursue our mission and vision.